Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 13 symbols : Nvsef save search
Global Heart Failure Drugs Market to Reach $10.2 Billion by 2026
Published: 2021-10-13 (Crawled : 14:15) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -3.12%
H: 0.0%
C: 0.0%
PFE | News A | $26.24 -0.08% 11M
|
Health Technology
|
| O: -0.24%
H: 0.38%
C: -0.79%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.46%
H: 0.62%
C: 0.08%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.08%
H: 1.43%
C: 0.87%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.57%
H: 1.61%
C: 0.99%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.0%
H: 0.58%
C: 0.02%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.5%
H: 1.04%
C: 0.33%
EXEL | $23.405 2.34% 850K
|
Health Technology
|
| O: 0.0%
H: 0.4%
C: 0.23%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: -0.43%
H: 1.08%
C: 0.73%
heart drug
NeoImmuneTech Announces First Patient Dosed in Phase 1b Study of NT-I7 (efineptakin alfa) and Kymriah® (tisagenlecleucel) in Relapsed/Refractory Large B-Cell Lymphoma
Published: 2021-10-13 (Crawled : 12:00) - biospace.com/
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.46%
H: 0.62%
C: 0.08%
phase 1 phase 1b t-cell phase 2b
Vision Care Market to record a CAGR of 3.83%|17000+ Technavio Research Reports
Published: 2021-10-13 (Crawled : 09:00) - prnewswire.com
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.46%
H: 0.62%
C: 0.08%
BHC | $8.5 0.59% 820K
|
Health Technology
|
| O: 0.5%
H: 0.48%
C: -0.39%
research
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.